Pfizer

The Johnson & Johnson COVID Vaccine Receives Emergency Use Authorization by the FDA

The J&J COVID vaccine received emergency use authorization (EUA) by the FDA this past weekend. This single-shot vaccine is the third COVID vaccine to be released in the United States, with plans to deliver 16 million doses to the federal government by the end of March. Due to production issues, this will be significantly less than the 37 million dose figure released by J&J while recommendation by the FDA was still under review. The first 3.9 million doses, created in J&J’s Netherland factory, are expected to arrive in America by today, March 2.

Read More »

The B.1.1.7 Coronavirus Variant

The B.1.1.7 coronavirus variant was first identified in the UK this past fall, emerging in Colorado soon thereafter. According to the CDC, there have been upwards of 1,000 cases caused by the B.1.1.7 variant across 34 states as of February 9, 2021. California and Florida, two states that have taken vastly different approaches for containing the novel coronavirus, have both reported the highest numbers of B.1.1.7 cases. 

Read More »

Key Points From Dr. Fauci’s Coronavirus Update

In a live video update on February 3, 2021, Dr. Anthony Fauci, Director of NIAID, spoke with Dr. Howard Bauchner, editor and chief from the JAMA Network, about the status of the coronavirus pandemic in the U.S. Dr. Fauci started off by explaining that our current challenge with regard to vaccines is the issue of variants. While the overall efficacy of the vaccine is diminished with variants, it can still reduce severe cases of COVID-19. This is good news; however, we do still have to pay attention when it comes to the spread of variants.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.